Cargando…
NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is the most fatal type of breast cancer (BC). Due to the lack of relevant targeted drug therapy, in addition to surgery, chemotherapy is still the most common treatment option for TNBC. TNBC is heterogeneous, and different patients have an unusual sensitivity to...
Autores principales: | He, Xiangming, Gu, Jinping, Zou, Dehong, Yang, Hongjian, Zhang, Yongfang, Ding, Yuqing, Teng, Lisong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592909/ https://www.ncbi.nlm.nih.gov/pubmed/34796199 http://dx.doi.org/10.3389/fmolb.2021.708052 |
Ejemplares similares
-
Studying Metabolism by NMR-Based Metabolomics
por: Moco, Sofia
Publicado: (2022) -
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023) -
Carbon Nanotubes Induce Metabolomic Profile Disturbances in Zebrafish: NMR-Based Metabolomics Platform
por: Ganesan, Raja, et al.
Publicado: (2021) -
Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging
por: Zhong, Anya B., et al.
Publicado: (2022) -
A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)